Aussie Scientists To Test Device To Deliver Tailor-Made Cancer Drugs
This article was originally published in PharmAsia News
Executive SummaryAustralian researchers expect to begin clinical trials soon to test a new device for delivering chemotherapy to cancer patients. The device is the EnGenlC Delivery Vehicle developed by a pair of Sydney doctors to enable nano cells to enter cancer cells. The EDV is designed to deliver drugs directly to solid tumors such as those involved in colon, head, liver, lung and rectal cancers. One of the developing physicians said successful trials could lead the way in changing treatment from "one size fits all" to tailor-made medicine. (Click here for more
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.